New drug combo aims to boost blood platelets in cancer patients
NCT ID NCT06769685
Summary
This study is testing a combination of two drugs to treat low platelet counts, a common and serious side effect of cancer treatments like chemotherapy. It will enroll 100 adult cancer patients who have developed this condition. The goal is to see how quickly and effectively the drug combination can raise platelet levels back to a safer range.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CTIT-CHEMOTHERAPY INDUCED THROMBOCYTOPENIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Jinhua Central Hospital
Jinhua, Zhejiang, 321000, China
Conditions
Explore the condition pages connected to this study.